Fanning the Flames of Growth: Q320 Extremities Market Recap

Written by Lisa Mahan | 12/14/20 3:45 PM

Return of elective procedures in Q320 fanned the flames of Extremities growth.

The return of elective procedures, along with the opening up of the US, fanned the flames of growth in the US with the Extremities Market returning to pre-COVID growth levels in Q320. Strength in both the Upper Extremities and Foot & Ankle Market fueled the fire with US Extremities heating up with +6.6% growth, according to SmartTRAK Financial Dashboard. The US Shoulder Replacement market segment brought the heat in US Upper Extremities which grew +6.3%, while Foot & Ankle Fixation and Ankle Replacement were also up, adding fuel to the fire in the Foot & Ankle market segment.

Among the many topics covered in the comprehensive Q320 Extremities Market Recap* are:

Complete Market Overview and Highlights
Extremities M&A Activity
Extremities Fixation: The Revival of Elective Procedures and Increased Activity Heats Up the Segment
Arthroplasty: New Product Launches and Assistive Technologies Drive Growth
Q320 Regulatory Highlights

M&A activity continued into Q320 with Stryker* making moves to offload some of its Extremities product lines− STAR ankle* and the Silicone Surface Replacement (SR MCP and PIP) and TACTYS finger arthroplasty implants − to DJO Global in preparation for its acquisition of ...

Read the entire Q320 Extremities Market Recap including news, data, charts, company revenues, shares and analysis*

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.

View full post